» Articles » PMID: 36424795

Lipoprotein (a) Levels and Abdominal Aortic Aneurysm. A Systematic Review and Meta-analysis

Abstract

Background: Several studies have linked high Lipoprotein (a) (Lp(a)) concentrations to cardiovascular events, including the formation of Abdominal Aortic Aneurysms (AAA). We review and meta-analyze existing evidence on the association of Lp(a) levels with AAA.

Methods: Studies evaluating the link of Lp(a) with AAA, up to December 27th 2021, were identified by a systematic search of PubMed, SCOPUS, and Web of Science databases. The results were qualitatively and quantitatively synthesized according to PRISMA guidelines. Results are presented as standardized mean differences (SMD) with 95% confidence intervals (CI).

Results: A total of 5,078 subjects (1,637 patients with AAA vs. 3,441 controls) from 11 studies were included in the meta-analysis, with a mean age of 69.9 years and a male sex prevalence of 85.8%. Based on the qualitative synthesis, high Lp(a) concentrations are linked to abdominal aortic wall degradation and extracellular matrix disarrangement. Moreover, despite the considerable variability among races, high Lp(a) levels are related to increased AAA risk, independently of race differences. Accordingly, patients with AAA displayed significantly higher Lp(a) levels compared to controls (SMD: 0.86, 95% CI: 0.55-1.17, p < 0.001). The outcome was not affected in a sensitivity analysis excluding three outlying studies (SMD: 0.40, 95% CI: 0.22-0.58, p < 0.001).

Conclusion: This meta-analysis indicates the association between high Lp(a) levels and the presence of AAA, although existing literature presents high heterogeneity. Further studies are needed to standardize Lp(a) measurements and to conclude whether Lp(a) can be used as a sensitive biomarker of early presymptomatic AAA diagnosis.

Citing Articles

Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a).

Kosmas C, Bousvarou M, Papakonstantinou E, Tsamoulis D, Koulopoulos A, Echavarria Uceta R Int J Mol Sci. 2023; 24(17).

PMID: 37686428 PMC: 10487774. DOI: 10.3390/ijms241713622.


Pathogenesis and management of abdominal aortic aneurysm.

Golledge J, Thanigaimani S, Powell J, Tsao P Eur Heart J. 2023; 44(29):2682-2697.

PMID: 37387260 PMC: 10393073. DOI: 10.1093/eurheartj/ehad386.


Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure.

Tsigkou V, Oikonomou E, Anastasiou A, Lampsas S, Zakynthinos G, Kalogeras K Int J Mol Sci. 2023; 24(5).

PMID: 36901752 PMC: 10001590. DOI: 10.3390/ijms24054321.


Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment.

Lampsas S, Xenou M, Oikonomou E, Pantelidis P, Lysandrou A, Sarantos S Molecules. 2023; 28(3).

PMID: 36770634 PMC: 9918959. DOI: 10.3390/molecules28030969.

References
1.
Purushothaman K, Purushothaman M, Levy A, Lento P, Evrard S, Kovacic J . Increased expression of oxidation-specific epitopes and apoptosis are associated with haptoglobin genotype: possible implications for plaque progression in human atherosclerosis. J Am Coll Cardiol. 2012; 60(2):112-9. DOI: 10.1016/j.jacc.2012.04.011. View

2.
Teles J, Teles N, Sousa H . SCREENING OF THE ABDOMINAL AORTIC ANEURYSM: COST-EFFECTIVENESS AND HEALTH BENEFITS. Port J Card Thorac Vasc Surg. 2022; 28(2):39-48. DOI: 10.48729/pjctvs.168. View

3.
Rehberger Likozar A, Zavrtanik M, Sebestjen M . Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options. Ann Med. 2020; 52(5):162-177. PMC: 7877976. DOI: 10.1080/07853890.2020.1775287. View

4.
Lim T, Yun J, Cha S, Song K, Yoo K, Ahn Y . Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study. Korean J Intern Med. 2016; 31(6):1110-1119. PMC: 5094932. DOI: 10.3904/kjim.2016.030. View

5.
Kubota Y, Folsom A, Ballantyne C, Tang W . Lipoprotein(a) and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study. Atherosclerosis. 2017; 268:63-67. PMC: 5788200. DOI: 10.1016/j.atherosclerosis.2017.10.017. View